172 related articles for article (PubMed ID: 20193090)
1. Computational analysis of binding between malarial dihydrofolate reductases and anti-folates.
Choowongkomon K; Theppabutr S; Songtawee N; Day NP; White NJ; Woodrow CJ; Imwong M
Malar J; 2010 Mar; 9():65. PubMed ID: 20193090
[TBL] [Abstract][Full Text] [Related]
2. An amino acid substitution in the Babesia bovis dihydrofolate reductase-thymidylate synthase gene is correlated to cross-resistance against pyrimethamine and WR99210.
Gaffar FR; Wilschut K; Franssen FF; de Vries E
Mol Biochem Parasitol; 2004 Feb; 133(2):209-19. PubMed ID: 14698433
[TBL] [Abstract][Full Text] [Related]
3. Cloning and heterologous expression of Plasmodium ovale dihydrofolate reductase-thymidylate synthase gene.
Tirakarn S; Riangrungroj P; Kongsaeree P; Imwong M; Yuthavong Y; Leartsakulpanich U
Parasitol Int; 2012 Jun; 61(2):324-32. PubMed ID: 22234170
[TBL] [Abstract][Full Text] [Related]
4. Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.
Hastings MD; Sibley CH
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13137-41. PubMed ID: 12198181
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence.
Eldin de Pécoulas P; Basco LK; Tahar R; Ouatas T; Mazabraud A
Gene; 1998 Apr; 211(1):177-85. PubMed ID: 9573357
[TBL] [Abstract][Full Text] [Related]
6. Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.
Somsak V; Uthaipibull C; Prommana P; Srichairatanakool S; Yuthavong Y; Kamchonwongpaisan S
Malar J; 2011 Oct; 10():291. PubMed ID: 21981896
[TBL] [Abstract][Full Text] [Related]
7. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure.
Imwong M; Pukrittayakamee S; Rénia L; Letourneur F; Charlieu JP; Leartsakulpanich U; Looareesuwan S; White NJ; Snounou G
Antimicrob Agents Chemother; 2003 May; 47(5):1514-21. PubMed ID: 12709316
[TBL] [Abstract][Full Text] [Related]
8. Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli.
Tahar R; de Pécoulas PE; Basco LK; Chiadmi M; Mazabraud A
Mol Biochem Parasitol; 2001 Apr; 113(2):241-9. PubMed ID: 11295178
[TBL] [Abstract][Full Text] [Related]
9. Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance.
Santos-Filho OA; de Alencastro RB; Figueroa-Villar JD
Biophys Chem; 2001 Jul; 91(3):305-17. PubMed ID: 11551441
[TBL] [Abstract][Full Text] [Related]
10. Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance.
Rastelli G; Sirawaraporn W; Sompornpisut P; Vilaivan T; Kamchonwongpaisan S; Quarrell R; Lowe G; Thebtaranonth Y; Yuthavong Y
Bioorg Med Chem; 2000 May; 8(5):1117-28. PubMed ID: 10882022
[TBL] [Abstract][Full Text] [Related]
11. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
[TBL] [Abstract][Full Text] [Related]
12. Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene.
Khim N; Kim S; Bouchier C; Tichit M; Ariey F; Fandeur T; Chim P; Ke S; Sum S; Man S; Ratsimbasoa A; Durand R; Ménard D
Antimicrob Agents Chemother; 2012 Feb; 56(2):863-8. PubMed ID: 22123682
[TBL] [Abstract][Full Text] [Related]
13. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.
Hastings MD; Maguire JD; Bangs MJ; Zimmerman PA; Reeder JC; Baird JK; Sibley CH
Antimicrob Agents Chemother; 2005 Feb; 49(2):733-40. PubMed ID: 15673758
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.
Leartsakulpanich U; Imwong M; Pukrittayakamee S; White NJ; Snounou G; Sirawaraporn W; Yuthavong Y
Mol Biochem Parasitol; 2002 Jan; 119(1):63-73. PubMed ID: 11755187
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of Plasmodium vivax anti-folate resistance in India.
Prajapati SK; Joshi H; Dev V; Dua VK
Malar J; 2011 Apr; 10():102. PubMed ID: 21513569
[TBL] [Abstract][Full Text] [Related]
16. Modeling the inhibition of quadruple mutant Plasmodium falciparum dihydrofolate reductase by pyrimethamine derivatives.
Fogel GB; Cheung M; Pittman E; Hecht D
J Comput Aided Mol Des; 2008 Jan; 22(1):29-38. PubMed ID: 18071909
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling of wild-type and antifolate resistant mutant Plasmodium falciparum DHFR.
Delfino RT; Santos-Filho OA; Figueroa-Villar JD
Biophys Chem; 2002 Aug; 98(3):287-300. PubMed ID: 12128181
[TBL] [Abstract][Full Text] [Related]
18. Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites.
Fohl LM; Roos DS
Mol Microbiol; 2003 Nov; 50(4):1319-27. PubMed ID: 14622418
[TBL] [Abstract][Full Text] [Related]
19. Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan.
Zakeri S; Afsharpad M; Ghasemi F; Raeisi A; Safi N; Butt W; Atta H; Djadid ND
Malar J; 2010 Mar; 9():75. PubMed ID: 20226087
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
